Linwei Dan

Linwei Dan

Auto-generated profile, based on publicly available information

Linwei Dan

Shaanxi University of Chinese Medicine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
CLChenwang Liu
Chenwang Liu
XSXiaomei Song
Xiaomei Song
YLYuze Li
Yuze Li
CDChao Ding
Chao Ding
XLXin Li
Xin Li
DZDongdong Zhang
Dongdong Zhang

1 January 2024 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
YWYing Wu
Ying Wu
CDChao Ding
Chao Ding
CLChenwang Liu
Chenwang Liu
LDLinwei Dan
Linwei Dan
HXHaonan Xu
Haonan Xu
DZDongdong Zhang
Dongdong Zhang

26 December 2024 in Records of Natural Products
Verified
Journal Article
Closed access
YLYuze Li
Yuze Li
YLYaxiao Liu
Yaxiao Liu
XZXinyu Zhang
Xinyu Zhang
YWYuxuan Wang
Yuxuan Wang
LDLinwei Dan
Linwei Dan
WWWei Wang
Wei Wang
Cortex Daphnes, a traditional Chinese medicine, has been utilized in China for millennia owing to it’s anti-inflammatory and analgesic properties. As it is belonging to the Thymelaeaceae family within the genus Daphne, it has traditionally been employed to dispel wind, eliminate dampness, alleviate pain, and dissipate blood stasis. Consequently, numerous scholars both domestically and internationally have investigated it’s chemical composition, pharmacological effects, and various other aspectsAmong these, daphnetin stands out as the primary active constituent in C. Daphnes, holding significant value as a precursor molecule for drug development. Pharmacological research has demonstrated that compounds and extracts derived from C. Daphnes exhibit notable activities, including anti-inflammatory, anti-tumor, antibacterial, immunomodulatory, antioxidant, and analgesic effects. Clinically, C. Daphnes has a long-standing history of use in the treatment of rheumatic diseases. This presents considerable potential for further development and exploration. According to existing records, C. Daphnes exhibits low toxicity; therefore, refining its processing technology, conducting toxicological studies, and establishing a comprehensive quality standard system are current challenges that need to be addressed. In this review, the botany, traditional uses, phytochemistry, pharmacology, and clinical applications of C. Daphnes, with the aim of providing a valuable reference for its future development and resource utilization was summarized.

11 February 2024 in Records of Natural Products
Verified
Journal Article
Closed access
DZDongdong Zhang
Dongdong Zhang
LDLinwei Dan
Linwei Dan
TGTianhui Gao
Tianhui Gao
YZYuying Zhang
Yuying Zhang
CGChuanming Gong
Chuanming Gong
XSXiaomei Song
Xiaomei Song
Panacis majoris Rhizoma (PMR) is a traditional Chinese medicine with tonic, hemostatic, and pain-relieving properties, classified under the genus Panax in the family Araliaceae. With a lengthy history of folk usage, PMR holds considerable potential for further development and exploration. Modern research indicates that saponins are the main active constituents. To date, a total of 122 compounds have been isolated from PMR, with the vast majority being triterpenoid saponins. In addition, there are small amounts of flavonoids, aromatic hydrocarbons, alkynes, and volatile oils. Pharmacological studies have demonstrated that compounds and extracts from PMR exhibit notable activities, including hepatoprotective, anti-cancer, cardioprotective, anti-ischemic brain injury, antioxidant, anti-inflammatory, analgesic, and anticoagulant effects. These compounds, serving as precursor molecules for drug development, are of significant value. This article provides a comprehensive review of PMR’s botany, phytochemistry, pharmacology, and clinical applications, offering valuable insights for its subsequent development and resource utilization.

26 October 2024 in Records of Natural Products
Verified
Journal Article
Closed access
DZDongdong Zhang
Dongdong Zhang
YWYing Wu
Ying Wu
CDChao Ding
Chao Ding
LDLinwei Dan
Linwei Dan
JTJiamei Tang
Jiamei Tang
XSXiaomei Song
Xiaomei Song
Schisandra chinensis (S. chinensis) is the dried mature fruit of Schisandra chinensis (Turcz.) Baill. Its primary active elements include polysaccharides, lignans, and other substances, and it is essential for neuroprotection, hepatoprotection, anti-inflammatory, antioxidant, and other functions. One of the components of lignan, schisantherin B (STB), is commonly extracted using ultrasonic extraction or a combination of ultrasonic and microwave techniques. The macroporous resin method is used to purify the extract at first. Pharmacological studies have shown that it has hepatoprotective, antitumor, and neuroprotective effects, among which hepatoprotective effects are more prominent, mainly by reducing the activity of intrahepatic ghrelin transaminase and improving liver damage. In addition, the pharmacokinetic analysis demonstrated that STB was well absorbed in vivo and was mainly in the form of passive transport in the gastrointestinal tract. The metabolic pathways in rats were also relatively diverse. At the same time, its content is related to the herb's traits, processing, storage methods, distribution, and other aspects. Therefore, the preparation, pharmacological effects, pharmacokinetic characteristics, and content determination of STB will be summarized, aiming to improve its knowledge system and provide a theoretical basis for subsequent more in-depth studies.